bismuth subsalicylate 17.4 MG/ML Oral Suspension
- RxCUI
- 422011
- RxNorm name
- bismuth subsalicylate 17.4 MG/ML Oral Suspension
- Display name
- bismuth subsalicylate 17.4 MG/ML Oral Suspension
- Full name
- bismuth subsalicylate 17.4 MG/ML Oral Suspension
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0a03a7c2-212d-4fd3-a78a-616e59db3a41 | bismuth subsalicylate 87 MG in 5 mL Oral Suspension [PSN] · bismuth subsalicylate 17.4 MG/ML Oral Suspension [SCD] · bismuth subsalicylate 87 MG per 5 ML Oral Suspension [SY] | 3 | 3 | Bismuth | 20221110 |
| 36441ed4-7f17-45bb-94a9-5fc509266f69 | bismuth subsalicylate 87 MG in 5 mL Oral Suspension [PSN] · bismuth subsalicylate 17.4 MG/ML Oral Suspension [SCD] · bismuth subsalicylate 87 MG per 5 ML Oral Suspension [SY] | 3 | 2 | Bismusal Suspension | 20221114 |